Paper422700
Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man.
Liljenquist JE and 4 others. J Clin Endocrinol Metab, 1979. Cited by 126 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man. Papers, record 422700. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/422700
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glucagon | Major topic |
| Glucose | Major topic |
| Hyperglycemia | Major topic |
| Insulin | Major topic |
| Liver | Major topic |
| Blood Glucose | |
| Humans | |
| Male | |
| Somatostatin |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38739548 | Estimation of Glucose Absorption, Insulin Sensitivity, and Glucose Effectiveness From the Oral Glucose Tolerance Test. | J Clin Endocrinol Metab | 2025 | https://conductscience.org/library/papers/38739548 | PubMed |
| 30789980 | Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose-Tolerant Participants. | J Clin Endocrinol Metab | 2019 | https://conductscience.org/library/papers/30789980 | PubMed |
| 26714848 | Modeling changes in glucose and glycerol rates of appearance when true basal rates of appearance cannot be readily determined. | Am J Physiol Endocrinol Metab | 2016 | https://conductscience.org/library/papers/26714848 | PubMed |
| 25869240 | The forgotten role of glucose effectiveness in the regulation of glucose tolerance. | Curr Diab Rep | 2015 | https://conductscience.org/library/papers/25869240 | PubMed |
| 19417129 | Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production. | Am J Physiol Endocrinol Metab | 2009 | https://conductscience.org/library/papers/19417129 | PubMed |
| 12819901 | Direct and indirect effects of amino acids on hepatic glucose metabolism in humans. | Diabetologia | 2003 | https://conductscience.org/library/papers/12819901 | PubMed |
| 9502760 | Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. | J Clin Invest | 1998 | https://conductscience.org/library/papers/9502760 | PubMed |
| 8609218 | The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8609218 | PubMed |
| 8550854 | Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8550854 | PubMed |
| 8182159 | Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. | J Clin Invest | 1994 | https://conductscience.org/library/papers/8182159 | PubMed |
| 7287908 | Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. | J Clin Invest | 1981 | https://conductscience.org/library/papers/7287908 | PubMed |
| 7042428 | Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. | Diabetologia | 1982 | https://conductscience.org/library/papers/7042428 | PubMed |
| 6754516 | Differential effects of insulin therapy on hepatic and peripheral insulin sensitivity in Type 2 (non-insulin-dependent) diabetes. | Diabetologia | 1982 | https://conductscience.org/library/papers/6754516 | PubMed |
| 6750603 | Insulin resistance and decreased insulin response to glucose in lean type 2 diabetics. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6750603 | PubMed |
| 6749586 | Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetes mellitus. | Diabetologia | 1982 | https://conductscience.org/library/papers/6749586 | PubMed |
| 6409929 | Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6409929 | PubMed |
| 6373828 | Differential roles of splanchnic and peripheral tissues in the pathogenesis of impaired glucose tolerance. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6373828 | PubMed |
| 6368585 | Influence of hyperglycemia on insulin's in vivo effects in type II diabetes. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6368585 | PubMed |
| 6138367 | Effect of fatty acids on glucose production and utilization in man. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6138367 | PubMed |
| 6123524 | Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man. | J Clin Invest | 1982 | https://conductscience.org/library/papers/6123524 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GCG | 2641 | PubTator's text mining | https://conductscience.org/library/genes/2641 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| SST | 6750 | PubTator's text mining | https://conductscience.org/library/genes/6750 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/422700
GET https://conductscience.org/api/papers/v1/422700/cited_by?page=2